EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The histone deacetylase HDAC1 controls dendritic cell development and anti-tumor immunity

Cristiano De Sá Fernandes, Philipp Novoszel, Tommaso Gastaldi, Dana Krauß, Magdalena Lang, Ramona Rica, Ana P Kutschat, Martin Holcmann, Wilfried Ellmeier, Davide Seruggia, Herbert Strobl, Maria Sibilia

Cell Reports · 2024-06 · 43 (6) · 114308

DOI: 10.1016/j.celrep.2024.114308 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2024-06. Verfasst von Cristiano De Sá Fernandes und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cancer Research, Medical University of Vienna, Comprehensive Cancer Center, Vienna, Austria. Hauptthemen laut MEDLINE: Dendritic Cells, Histone Deacetylase 1, Cell Differentiation. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Commission Marie Sklodowska-Curie Actions, FWF, Medizinische Universität Wien.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsHistone Deacetylase 1Cell DifferentiationAnimalsHumansMiceMice, Inbred C57BLAcetylationNeoplasmsHistonesCD8-Positive T-LymphocytesHistone Deacetylase 2Interleukin-12

Stichwörter der Autor:innen

ATAC-seqCP: CancerCP: ImmunologyCut&RunHDACIRFcDC1cDC2dendritic cellepigeneticspDCtumor immunity

Substanzen

Histone Deacetylase 1HistonesHistone Deacetylase 2Interleukin-12Hdac1 protein, mouse

Autor:innen und Institutionen

  • Center for Cancer Research, Medical University of Vienna, Comprehensive Cancer Center, Vienna, Austria.
  • Division of Immunology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.
  • Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
  • St. Anna Children's Cancer Research Institute, Vienna, Austria; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Center for Cancer Research, Medical University of Vienna, Comprehensive Cancer Center, Vienna, Austria. Electronic address: maria.sibilia@meduniwien.ac.at.

Förderung

  • European Commission Marie Sklodowska-Curie Actions
  • FWF
  • Medizinische Universität Wien
  • H2020 European Research Council
  • H2020 Marie Skłodowska-Curie Actions
  • European Research Council

Zitieren

APA

De Sá Fernandes, C., Novoszel, P., Gastaldi, T., Krauß, D., Lang, M., Rica, R., Kutschat, A. P., Holcmann, M., Ellmeier, W., Seruggia, D., Strobl, H., & Sibilia, M. (2024). The histone deacetylase HDAC1 controls dendritic cell development and anti-tumor immunity. Cell Reports, 43(6), 114308. https://doi.org/10.1016/j.celrep.2024.114308

Vancouver

De Sá Fernandes C, Novoszel P, Gastaldi T, Krauß D, Lang M, Rica R, et al. The histone deacetylase HDAC1 controls dendritic cell development and anti-tumor immunity. Cell Reports. 2024;43(6):114308. doi:10.1016/j.celrep.2024.114308

BibTeX
@article{DeSFernandes2024,
  author = {De Sá Fernandes, Cristiano and Novoszel, Philipp and Gastaldi, Tommaso and Krauß, Dana and Lang, Magdalena and Rica, Ramona and Kutschat, Ana P and Holcmann, Martin and Ellmeier, Wilfried and Seruggia, Davide and Strobl, Herbert and Sibilia, Maria},
  title = {The histone deacetylase HDAC1 controls dendritic cell development and anti-tumor immunity},
  journal = {Cell Reports},
  year = {2024},
  volume = {43},
  number = {6},
  pages = {114308},
  doi = {10.1016/j.celrep.2024.114308}
}
Kostenlos starten →